Neal D. Shore, MD, FACS | Authors

Upfront Chemotherapy in Prostate Cancer

July 15, 2015

In this interview we discuss recent trials that looked at the use of upfront chemotherapy combined with androgen deprivation therapy in men with metastatic prostate cancer and how they have changed clinical practice.

New Biomarkers in Prostate Cancer

February 15, 2014

In this article, we review recent advances in the discovery of prostate cancer biomarkers, their integration into clinical practice, and implications for improving clinical management of the disease.

The Success of Therapies for Metastatic CRPC Continues

November 15, 2013

I have read multiple overviews of the current management of castration-resistant prostate cancer (CRPC). These articles have very adeptly summarized the key trials leading to a multitude of US Food and Drug Administration (FDA) approvals of new agents for men with CRPC.